Search Menu Cart 0 €

Login

Registration Restore password

SmartEIA Borrelia afzelii VlsE IgG

SmartEIA Borrelia afzelii VlsE IgG
EAN Code: 8595635305740
Catalog number: SK-BaGV96
Package size: 96 tests
Regulatory status: IVD CE
Storage: 2-8 °C
Producer: TestLine Clinical Diagnostics s.r.o.

Sample request

Sample ordering is possible only for registered users

If you are already registered, please log in
If you are new customer register

Contact person:

Name: MUDr. Jana Dočkalová
Phone: +420 549 121 205
E-mail: trade@testlinecd.com

The immunoenzymatic assay is intended for the diagnosis and monitoring of Borrelia afzelii infection using IgG antibodies in human serum, plasma, cerebrospinal fluid or synovial fluid in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory.

If you are already registered, please login

Request Product Export to PDF Print

Have a question?
Need a help?

Do not hesitate and call us or fill in a query form and we will contact you soon.

Description

Description:

·         Microtitre wells are coated with the sonicated whole-cell antigen of the Borrelia afzelii KC90 strain rich in OspA, OspC, p41 and p100.

·         If specific antibodies are present, they bind to the antigen, are labeled by the Conjugate in the following steps and are detected by color reaction with a single component substrate (TMB-Complete).

·         The kit allows 96 tests, including controls in a split microtiter plate with color-coded strips and breakable wells.

Advantages:

·         The total assay time is about 1 hour 30 min.

·         High sensitivity and specificity of the test.

·         Kit includes CUT-OFF, Positive Control and Negative Control.

·         Semi-quantitative evaluation in the Index of Positivity (IP).

·         Ready-to-use, color-coded components.

·         Single-component substrate.

·         Interchangeable components with the exception of kit specific components (Controls, Conjugate, Plate).

Application:

·         Screening test for the detection of Lyme borreliosis in humans.

·         Checking of therapy results using the semiquantitative determination.

Brief assay procedure:

1.       Dilute samples of serum/plasma (1:101), synovial fluid (1:21, 1:41) or cerebrospinal fluid (1:2).

2.       Pipette Controls and diluted Samples.

3.       Incubate at 37°C for 30 min.

4.       Aspirate and wash the wells 5×

5.       Pipette Conjugate.

6.       Incubate at 37°C for 30 min.

7.       Aspirate and wash the wells 5×

8.       Pipette Substrate (TMB-Complete).

9.       Incubate at 37°C for 15 min.

10.   Pipette Stop Solution.

11.   Read color intensity at 450 nm.

12.   Evaluate the test.

SmartEIA kits are specifically designed for automated processing on the Agility® instrument, Dynex Technologies, Inc.

Download